Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : System    source : Alzamend.com    save search
Alzamend Neuro Receives Positive Pre-IND Response from FDA for AL002, a Cell-Based Therapeutic Vaccine That Seeks to Restore the Ability of Patients’ Immunological System to Combat Alzheimer’s Disease
Published: 2022-01-12 (Crawled : 20:00) - alzamend.com
ALZN | $0.7256 5.93% 5.23% 20K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: 0.54% H: 7.03% C: -0.54%
al002 alzheimer fda system disease cel positive pons vaccine alzheimer’s alzheimer's disease alzheimer's
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M twitter stocktwits trandingview |

AGBA | $2.97 137.6% 57.48% 66M twitter stocktwits trandingview |
Finance
EDBL | News | $6.59 75.27% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.24 43.59% 30.67% 6M twitter stocktwits trandingview |
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M twitter stocktwits trandingview |
Finance
SHIM | $3.045 35.33% 26.23% 870K twitter stocktwits trandingview |

HKIT | $1.33 30.39% 24.16% 390K twitter stocktwits trandingview |
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M twitter stocktwits trandingview |
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.